Mary Carrington
Cancer and Inflammation Program
Laboratory of Experimental Immunology
SAIC-Frederick
Inc., NCI-Frederick
USA
Name/email consistency: high
- KIR-HLA intercourse in HIV disease. Carrington, M., Martin, M.P., van Bergen, J. Trends Microbiol. (2008)
- The impact of variation at the KIR gene cluster on human disease. Carrington, M., Martin, M.P. Curr. Top. Microbiol. Immunol. (2006)
- Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci. Carrington, M., Wang, S., Martin, M.P., Gao, X., Schiffman, M., Cheng, J., Herrero, R., Rodriguez, A.C., Kurman, R., Mortel, R., Schwartz, P., Glass, A., Hildesheim, A. J. Exp. Med. (2005)
- Justified chauvinism: advances in defining meiotic recombination through sperm typing. Carrington, M., Cullen, M. Trends Genet. (2004)
- The influence of HLA genotype on AIDS. Carrington, M., O'Brien, S.J. Annu. Rev. Med. (2003)
- Effects of MHC class I on HIV/SIV disease in primates. Carrington, M., Bontrop, R.E. AIDS (2002)
- Novel alleles of the chemokine-receptor gene CCR5. Carrington, M., Kissner, T., Gerrard, B., Ivanov, S., O'Brien, S.J., Dean, M. Am. J. Hum. Genet. (1997)